{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/673da99fd1a6d05d3c8e3f67/6aeda4f3dabcb4d1f2cf3532?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"KRAS (with Prof Debs Sarker)","description":"<p>In this bonus episode, Camilla and Kiruthikah are joined by Prof Debs Sarker, medical oncologist and clinical academic, to talk about the recent news on KRAS-targeted treatments for pancreatic cancer.</p><p><br></p><p>We’ll cover:</p><ul><li>what KRAS is, why it matters in pancreatic cancer and why it has been in the news</li><li>what the latest research shows so far, and which patients it applies to</li><li>why these treatments are not yet available, and the steps needed before they can be used in the clinic</li><li>what this news means for people living with pancreatic cancer now, and who to speak to if you have questions.</li></ul><p><br></p><p>For more on gene mutations and clinical trials, listen to our earlier episodes on genetics and clinical trials.</p><p><br></p><p>This episode gives a clear and balanced look at the KRAS news, helping people understand what it means for them and what to expect next.</p>","author_name":"Guy's Cancer Academy"}